NL-OMON48077
Completed
Not Applicable
ow-field MRI visualisation of gravity-dependent endograft migration in patients with suspected endoleaks after EVAR (endovascular aneurysm repair) - Gravity-dependent aortic endograft position with low-field MRI (GRAVEL)
niversiteit Twente0 sites10 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Aorta dilation
- Sponsor
- niversiteit Twente
- Enrollment
- 10
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
Trial is onging in other countries
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Patient had previous EVAR intervention
- •\- Implanted endograft: type Endurant or type Anaconda
- •\- Patient had/will have CTA follow\-up because of a suspected endoleak, or
- •growth of the aneurysm
- •\- Signed informed consent
- •\- Good knowledge of Dutch language
Exclusion Criteria
- •\- Hip waist \> 47 cm (because of MR coil restrictions)
- •\- Not eligible for MRI, in response to the MRI safety checklist
- •\- Inability to stand for 15 minutes, without assistance
- •\- Outdated (\>2 months) good contrast CTA scan
- •\- Previous re\-intervention to repair an endoleak after EVAR
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Magnetic Resonance Direct Thrombus Imaging for Suspected Thrombosis of Upper Extremity Diagnostic Evaluation (Selene Study)arm vein thrombosisupper extremity thrombosis10014523NL-OMON50636eids Universitair Medisch Centrum46
Completed
Not Applicable
Quantitative MR Imaging of skeletal muscle in Duchenne and Becker muscular dystrophyDuchenne muscular dystrophy10028302NL-OMON47455Radiologie74
Recruiting
Not Applicable
Visualizing gravity-dependent aortic endograft position with low-field MRINL-OMON20085niversity of Twente10
Completed
Not Applicable
Quantitative MRI of extra-ocular muscles in myasthenia gravisNL-OMON48436eids Universitair Medisch Centrum89
Completed
Not Applicable
An Abdominal Imaging, Substrate Analysis and Laboratory Sample Collection sub-study for Participants Who Have enrolled in LAL-2-NH01Lipid storage diseaseWolman Disease10027424NL-OMON37869Synageva Biopharma Corp2